Pages that link to "Q40066322"
Jump to navigation
Jump to search
The following pages link to MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines (Q40066322):
Displaying 50 items.
- TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu (Q21131200) (← links)
- MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma (Q21134039) (← links)
- MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs (Q24298306) (← links)
- MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases (Q24300816) (← links)
- The novel protein complex with SMARCAD1/KIAA1122 binds to the vicinity of TSS (Q24319514) (← links)
- Identification of novel small molecules that inhibit protein-protein interactions between MAGE and KAP-1 (Q24338624) (← links)
- Androgen receptor molecular biology and potential targets in prostate cancer (Q24602861) (← links)
- Updated overview of current biomarkers in head and neck carcinoma (Q26750659) (← links)
- Role of genetic detection in peritoneal washes with gastric carcinoma: The past, present and future (Q26753850) (← links)
- KAPtain in charge of multiple missions: Emerging roles of KAP1 (Q26822740) (← links)
- MAGE-C2/CT10 Protein Expression Is an Independent Predictor of Recurrence in Prostate Cancer (Q28478930) (← links)
- Melanoma-associated cancer-testis antigen 16 (CT16) regulates the expression of apoptotic and antiapoptotic genes and promotes cell survival (Q28483943) (← links)
- hnRNP K coordinates transcriptional silencing by SETDB1 in embryonic stem cells (Q28543055) (← links)
- The mouse Mageb18 gene encodes a ubiquitously expressed type I MAGE protein and regulates cell proliferation and apoptosis in melanoma B16-F0 cells (Q28586544) (← links)
- Differential evolution of MAGE genes based on expression pattern and selection pressure (Q28714314) (← links)
- Potential role for PAD2 in gene regulation in breast cancer cells. (Q28728858) (← links)
- Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer (Q33420388) (← links)
- T cell receptor (TCR) gene therapy to treat melanoma: lessons from clinical and preclinical studies (Q33530527) (← links)
- Bioinformatics analysis of the prognostic value of Tripartite Motif 28 in breast cancer (Q33598054) (← links)
- Frequent MAGE Mutations in Human Melanoma (Q33700477) (← links)
- Functional interaction between co-expressed MAGE-A proteins (Q33725090) (← links)
- Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase (Q33727985) (← links)
- Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ. (Q33743831) (← links)
- hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways (Q33913833) (← links)
- Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy (Q33957165) (← links)
- MAGE I Transcription Factors Regulate KAP1 and KRAB Domain Zinc Finger Transcription Factor Mediated Gene Repression (Q34005548) (← links)
- An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients. (Q34032518) (← links)
- Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines (Q34081748) (← links)
- Identification of MAGEA antigens as causal players in the development of tamoxifen-resistant breast cancer (Q34171827) (← links)
- MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies. (Q34196069) (← links)
- MAGE-A family: Attractive targets for cancer immunotherapy (Q34217938) (← links)
- Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy (Q34399765) (← links)
- A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer (Q34502501) (← links)
- Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity (Q34592273) (← links)
- miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma (Q34722558) (← links)
- Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications (Q34753747) (← links)
- HER2 as a promising target for cytotoxicity T cells in human melanoma therapy (Q34981712) (← links)
- MAGE-A inhibits apoptosis in proliferating myeloma cells through repression of Bax and maintenance of survivin (Q35091212) (← links)
- A Pathway for the Control of Anoikis Sensitivity by E-Cadherin and Epithelial-to-Mesenchymal Transition (Q35273882) (← links)
- The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex (Q35543268) (← links)
- MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4 (Q35637193) (← links)
- Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage (Q35786099) (← links)
- Cancer/Testis Antigen MAGE-C1/CT7: new target for multiple myeloma therapy. (Q35846167) (← links)
- Chemo/Photoacoustic Dual Therapy with mRNA-Triggered DOX Release and Photoinduced Shockwave Based on a DNA-Gold Nanoplatform (Q35872986) (← links)
- Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding (Q35933899) (← links)
- KAP1 Is a Host Restriction Factor That Promotes Human Adenovirus E1B-55K SUMO Modification (Q36434260) (← links)
- Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E. (Q36561664) (← links)
- MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repair (Q36605340) (← links)
- MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases (Q36642593) (← links)
- Epigenetic modulation of MAGE-A3 antigen expression in multiple myeloma following treatment with the demethylation agent 5-azacitidine and the histone deacetlyase inhibitor MGCD0103 (Q36786757) (← links)